Indivior Pharmaceuticals, Inc. — All Filings
503 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-12G
20-F
20FR12B
20FR12B/A
3
4
6-K
6-K/A
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
F-6
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF ACTION
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| ARS | ARS | 0001104659-26-035513 | Mar 27, 2026 | Dec 31, 2025 |
| DEFA14A | DEFA14A | 0001104659-26-035500 | Mar 27, 2026 | — |
| DEF 14A | DEF 14A | 0001104659-26-035480 | Mar 27, 2026 | May 13, 2026 |
| SCHEDULE 13G | — | 0001104659-26-033404 | Mar 23, 2026 | — |
| 4 | FORM 4 | 0002014866-26-000008 | Mar 17, 2026 | Mar 14, 2026 |
| 8-K | 8-K | 0001625297-26-000015 | Mar 17, 2026 | — |
| 4 | FORM 4 | 0001827169-26-000010 | Mar 13, 2026 | — |
| 8-K | 8-K | 0001625297-26-000012 | Mar 13, 2026 | Mar 12, 2026 |
| 8-K | 8-K | 0001625297-26-000008 | Mar 12, 2026 | — |
| 4 | FORM 4 | 0001369067-26-000006 | Mar 11, 2026 | Mar 6, 2026 |
| 4 | FORM 4 | 0001827169-26-000008 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | FORM 4 | 0002014440-26-000007 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0002014866-26-000006 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001484322-26-000013 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0002014639-26-000006 | Mar 5, 2026 | Mar 3, 2026 |
| 10-K | 10-K | 0001628280-26-012237 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-073363 | Feb 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001013594-26-000258 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001941040-26-000175 | Feb 17, 2026 | — |
| 4 | FORM 4 | 0002014440-26-000005 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | FORM 4 | 0002014866-26-000004 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | FORM 4 | 0001484322-26-000011 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | FORM 4 | 0002014639-26-000004 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | FORM 4 | 0001733376-26-000004 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0001443841-26-000004 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0001369067-26-000004 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0001789507-26-000006 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0001827169-26-000006 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0001257599-26-000006 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0001487937-26-000006 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0001715258-26-000004 | Jan 28, 2026 | Jan 26, 2026 |
| 4 | FORM 4 | 0002014900-26-000006 | Jan 28, 2026 | Jan 26, 2026 |
| 15-12G | 15-12G | 0001625297-26-000002 | Jan 26, 2026 | — |
| S-8 | S-8 | 0001193125-26-022583 | Jan 26, 2026 | — |
| S-8 POS | S-8 POS | 0001193125-26-022554 | Jan 26, 2026 | — |
| S-8 POS | S-8 POS | 0001193125-26-022544 | Jan 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-021660 | Jan 26, 2026 | Jan 23, 2026 |
| 8-K | 8-K | 0001193125-26-006993 | Jan 8, 2026 | — |
| SCHEDULE 13G/A | — | 0002012383-26-000035 | Jan 8, 2026 | — |
| 4 | FORM 4 | 0001827169-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0002014900-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001257599-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001487937-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001789507-26-000004 | Jan 7, 2026 | Jan 5, 2026 |
| 3 | FORM 3 | 0001827169-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001257599-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001369067-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001715258-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001487937-26-000002 | Jan 7, 2026 | Jan 1, 2026 |
| 3 | FORM 3 | 0001443841-26-000002 | Jan 7, 2026 | Jan 1, 2026 |